more

Amarin (AMRN)

(Delayed Data from NSDQ)

$0.79 USD

0.00 (-0.15%)

Updated Jul 23, 2024 03:58 PM ET

After-Market: $0.79 0.00 (0.25%) 4:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.15%
2	Buy	17.88%
3	Hold	9.47%
4	Sell	5.14%
5	Strong Sell	2.57%
S&P	500	11.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5 4

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

Top 33% (82 out of 250)

Industry: Medical - Biomedical and Genetics

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Amarin (AMRN) Beats Earnings & Misses Revenues in Q3

by Indrajit Bandyopadhyay Published on November 01,2018

Amarin beat earnings estimates while it misses sales in the third quarter of 2018.

AMRNNegative Net Change

What's in the Cards for Amarin (AMRN) This Earnings Season?

by Zacks Equity Research Published on October 29,2018

Amarin (AMRN) is scheduled to release third-quarter earnings on Nov 1.

Amarin (AMRN) Gains As Market Dips: What You Should Know

by Zacks Equity Research Published on October 26,2018

Amarin (AMRN) closed the most recent trading day at $21.96, moving +0.78% from the previous trading session.

AMRNNegative Net Change

Amarin (AMRN) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research Published on October 19,2018

Amarin (AMRN) closed the most recent trading day at $19.71, moving -1.99% from the previous trading session.

AMRNNegative Net Change

Amarin (AMRN) Stock Moves -1.51%: What You Should Know

by Zacks Equity Research Published on October 10,2018

In the latest trading session, Amarin (AMRN) closed at $17.34, marking a -1.51% move from the previous day.

AMRNNegative Net Change

5 Top Healthcare Mutual Funds to Buy in October

by Zacks Equity Research Published on October 02,2018

Successful drug trials at several biopharmas and FDA approvals make healthcare funds a strong investment option

5 Best Biotech Stocks to Buy In October

by Zacks Equity Research Published on October 01,2018

Successful drug trials at several biopharmas and FDA approvals make biotech companies a strong investment choice in October

Amarin's Stock Soars as Fish Oil Drug Lowers Heart Risks

by Zacks Equity Research Published on September 27,2018

Amarin (AMRN) shares soar on positive results from a cardiovascular outcomes study on Vascepa.

Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars

by Zacks Equity Research Published on September 26,2018

Data read-outs by quite a few companies grabbed headlines in the biotech sector this week.

Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?

by Zacks Equity Research Published on June 22,2018

Investors in Amarin (AMRN) need to pay close attention to the stock based on moves in the options market lately.

AMRNNegative Net Change

Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?

by Zacks Equity Research Published on May 21,2018

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

AMRNNegative Net Change

Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?

by Zacks Equity Research Published on April 24,2018

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

AMRNNegative Net Change

Moving Average Crossover Alert: Amarin (AMRN)

by Zacks Equity Research Published on April 12,2018

Amarin Corporation plc (AMRN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front